Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Price to Book Ratio 2006-2020 | BIIB

Historical price to book ratio values for Biogen (BIIB) over the last 10 years. The current price to book ratio for Biogen as of November 26, 2020 is 3.46.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Biogen Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2020-11-27 243.78 3.49
2020-09-30 283.68 $69.81 4.06
2020-06-30 267.55 $71.32 3.75
2020-03-31 316.38 $74.71 4.23
2019-12-31 296.73 $76.57 3.88
2019-09-30 232.82 $76.92 3.03
2019-06-30 233.87 $70.20 3.33
2019-03-31 236.38 $71.29 3.32
2018-12-31 300.92 $66.08 4.55
2018-09-30 353.31 $68.29 5.17
2018-06-30 290.24 $60.83 4.77
2018-03-31 273.82 $66.53 4.12
2017-12-31 318.57 $59.57 5.35
2017-09-30 313.12 $60.76 5.15
2017-06-30 271.36 $54.74 4.96
2017-03-31 273.42 $54.06 5.06
2016-12-31 261.39 $56.18 4.65
2016-09-30 288.53 $55.68 5.18
2016-06-30 222.89 $52.04 4.28
2016-03-31 239.95 $47.15 5.09
2015-12-31 282.37 $42.89 6.58
2015-09-30 268.35 $47.41 5.66
2015-06-30 372.33 $53.46 6.96
2015-03-31 389.19 $49.61 7.85
2014-12-31 312.88 $46.10 6.79
2014-09-30 304.92 $44.17 6.90
2014-06-30 290.63 $40.51 7.18
2014-03-31 281.93 $38.54 7.32
2013-12-31 257.69 $36.48 7.06
2013-09-30 221.92 $34.40 6.45
2013-06-30 198.36 $33.25 5.97
2013-03-31 177.54 $30.92 5.74
2012-12-31 134.91 $29.44 4.58
2012-09-30 137.53 $28.16 4.88
2012-06-30 133.08 $26.53 5.02
2012-03-31 116.14 $26.33 4.41
2011-12-31 101.44 $26.55 3.82
2011-09-30 85.86 $25.66 3.35
2011-06-30 98.55 $24.97 3.95
2011-03-31 67.72 $23.48 2.88
2010-12-31 61.80 $22.66 2.73
2010-09-30 51.73 $21.28 2.43
2010-06-30 43.74 $21.54 2.03
2010-03-31 52.90 $22.29 2.37
2009-12-31 49.31 $21.71 2.27
2009-09-30 46.57 $22.81 2.04
2009-06-30 41.62 $21.62 1.92
2009-03-31 48.32 $20.86 2.32
2008-12-31 43.90 $20.25 2.17
2008-09-30 46.35 $19.77 2.34
2008-06-30 51.52 $19.03 2.71
2008-03-31 56.86 $18.88 3.01
2007-12-31 52.47 $18.72 2.80
2007-09-30 61.14 $17.02 3.59
2007-06-30 49.31 $16.10 3.06
2007-03-31 40.91 $21.47 1.91
2006-12-31 45.34 $21.14 2.14
2006-09-30 41.18 $20.45 2.01
2006-06-30 42.69 $20.40 2.09
2006-03-31 43.41 $20.77 2.09
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $37.201B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.187B 10.14
Amgen (AMGN) United States $128.258B 13.41
CSL (CSLLY) Australia $104.516B 0.00
Gilead Sciences (GILD) United States $74.585B 9.92
Vertex Pharmaceuticals (VRTX) United States $56.714B 26.37
Regeneron Pharmaceuticals (REGN) United States $54.240B 19.24
Illumina (ILMN) United States $44.381B 61.04
Moderna (MRNA) United States $43.204B 0.00
Seagen (SGEN) United States $29.832B 78.79
Alexion Pharmaceuticals (ALXN) United States $26.903B 10.72
BeiGene (BGNE) Cayman Islands $23.985B 0.00
BioNTech SE (BNTX) Germany $23.748B 0.00
Genmab (GMAB) Denmark $23.537B 27.84
Genmab (GNMSF) Denmark $22.400B 5.16
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.774B 0.00
Exact Sciences (EXAS) United States $17.430B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.674B 59.44
Horizon Therapeutics Public (HZNP) Ireland $15.207B 21.74
Alnylam Pharmaceuticals (ALNY) United States $14.575B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.187B 94.16
ARGENX SE-ADR (ARGX) Netherlands $12.480B 0.00
Bio-Techne Corp (TECH) United States $11.650B 74.51
Mirati Therapeutics (MRTX) United States $11.336B 0.00
Guardant Health (GH) United States $11.261B 0.00
QIAGEN (QGEN) Netherlands $10.761B 24.23
Sarepta Therapeutics (SRPT) United States $10.710B 0.00
Repligen (RGEN) United States $9.547B 135.40
ACADIA Pharmaceuticals (ACAD) United States $8.881B 0.00
Ascendis Pharma (ASND) Denmark $8.661B 0.00
Galapagos (GLPG) Belgium $7.892B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.772B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.315B 0.00
Denali Therapeutics (DNLI) United States $7.269B 0.00
Acceleron Pharma (XLRN) United States $6.854B 0.00
Novavax (NVAX) United States $6.532B 0.00
Adaptive Biotechnologies (ADPT) United States $6.268B 0.00
Amicus Therapeutics (FOLD) United States $5.931B 0.00
Blueprint Medicines (BPMC) United States $5.870B 19.43
Exelixis (EXEL) United States $5.811B 39.02
Halozyme Therapeutics (HALO) United States $5.561B 257.13
SWEDISH ORP BIO (BIOVF) Sweden $5.208B 14.23
Reata Pharmaceuticals (RETA) United States $5.146B 0.00
NeoGenomics (NEO) United States $5.075B 1523.67
Fate Therapeutics (FATE) United States $4.984B 0.00
China Biologic Products (CBPO) China $4.674B 30.29
Twist Bioscience (TWST) United States $4.450B 0.00
Emergent Biosolutions (EBS) United States $4.262B 13.98
Insmed (INSM) United States $3.930B 0.00
Arena Pharmaceuticals (ARNA) United States $3.810B 0.00
Legend Biotech (LEGN) United States $3.760B 0.00
Vir Biotechnology (VIR) United States $3.619B 0.00
MorphoSys AG (MOR) Germany $3.532B 127.86
Deciphera Pharmaceuticals (DCPH) United States $3.518B 0.00
Eidos Therapeutics (EIDX) United States $3.430B 0.00
Alkermes (ALKS) Ireland $2.933B 28.80
Bluebird Bio (BLUE) United States $2.869B 0.00
Global Blood Therapeutics (GBT) United States $2.710B 0.00
Seres Therapeutics (MCRB) United States $2.682B 0.00
Beam Therapeutics (BEAM) United States $2.591B 0.00
Zymeworks (ZYME) Canada $2.225B 0.00
Intellia Therapeutics (NTLA) United States $2.119B 0.00
I-Mab (IMAB) China $2.111B 0.00
Viela Bio (VIE) United States $2.073B 0.00
UniQure (QURE) Netherlands $2.069B 0.00
Intra-Cellular Therapies (ITCI) United States $2.051B 0.00
PHARMA MAR SA (PHMMF) Spain $1.921B 0.00
Editas Medicine (EDIT) United States $1.836B 0.00
Sorrento Therapeutics (SRNE) United States $1.814B 0.00
Amarin (AMRN) Ireland $1.799B 0.00
Mesoblast (MESO) Australia $1.793B 0.00
Inovio Pharmaceuticals (INO) United States $1.760B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.754B 0.00
Mersana Therapeutics (MRSN) United States $1.705B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.674B 0.00
Revance Therapeutics (RVNC) United States $1.631B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Arcus Biosciences (RCUS) United States $1.582B 0.00
NGM Biopharmaceuticals (NGM) United States $1.572B 0.00
Scholar Rock Holding (SRRK) United States $1.504B 0.00
Alcobra (ARCT) United States $1.485B 0.00
Zealand Pharma (ZEAL) Denmark $1.444B 0.00
Ligand Pharmaceuticals (LGND) United States $1.406B 36.42
Precigen (PGEN) United States $1.387B 0.00
Sangamo Therapeutics (SGMO) United States $1.382B 0.00
Myriad Genetics (MYGN) United States $1.370B 0.00
Adverum Biotechnologies (ADVM) United States $1.346B 0.00
REGENXBIO (RGNX) United States $1.334B 0.00
Coherus BioSciences (CHRS) United States $1.300B 8.60
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Athenex (ATNX) United States $1.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.234B 0.00
Epizyme (EPZM) United States $1.204B 0.00
Heska (HSKA) United States $1.195B 0.00
Cytokineticsorporated (CYTK) United States $1.174B 0.00
Genetron Holdings (GTH) China $1.173B 0.00
Travere Therapeutics (TVTX) United States $1.164B 0.00
Vericel (VCEL) United States $1.134B 0.00
Codexis (CDXS) United States $1.059B 0.00
Pliant Therapeutics (PLRX) United States $1.056B 0.00
Alector (ALEC) United States $1.053B 0.00
Morphic Holding (MORF) United States $1.014B 0.00
Northwest Biotherapeutics (NWBO) United States $1.014B 0.00
Cellectis S.A (CLLS) France $0.953B 0.00
Arvinas (ARVN) United States $0.950B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.945B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.900B 0.00
Protagonist Therapeutics (PTGX) United States $0.885B 0.00
Frequency Therapeutics (FREQ) United States $0.879B 0.00
Castle Biosciences (CSTL) United States $0.868B 0.00
Celldex Therapeutics (CLDX) United States $0.861B 0.00
Compugen (CGEN) Israel $0.844B 0.00
NantKwest (NK) United States $0.819B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 17.19
Cardiff Oncology (CRDF) United States $0.753B 0.00
Cara Therapeutics (CARA) United States $0.750B 0.00
MiMedx (MDXG) United States $0.726B 0.00
Albireo Pharma (ALBO) United States $0.705B 0.00
Five Prime Therapeutics (FPRX) United States $0.702B 0.00
Kadmon Holdings (KDMN) United States $0.696B 0.00
MannKind (MNKD) United States $0.686B 0.00
AnaptysBio (ANAB) United States $0.675B 0.00
Agenus (AGEN) United States $0.667B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.662B 33.64
VBI Vaccines (VBIV) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Sutro Biopharma (STRO) United States $0.637B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.635B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.626B 0.00
Precision BioSciences (DTIL) United States $0.604B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
IVERIC Bio (ISEE) United States $0.564B 0.00
Geron (GERN) United States $0.562B 0.00
Anika Therapeutics (ANIK) United States $0.544B 73.56
Aquinox Pharmaceuticals (NLTX) United States $0.534B 0.00
MeiraGTx Holdings (MGTX) United States $0.527B 0.00
Avid Bioservices (CDMO) United States $0.497B 0.00
Forte Biosciences (FBRX) United States $0.490B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
Merus (MRUS) Netherlands $0.471B 0.00
Dynavax Technologies (DVAX) United States $0.468B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.466B 0.00
WAVE Life Sciences (WVE) Singapore $0.449B 0.00
Prothena (PRTA) Ireland $0.446B 0.00
Puma Biotechnology (PBYI) United States $0.439B 0.00
Spero Therapeutics (SPRO) United States $0.433B 0.00
Amryt Pharma (AMYT) United Kingdom $0.430B 0.00
UROGEN PHARMA (URGN) United States $0.426B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.417B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Innate Pharma S.A (IPHA) France $0.409B 0.00
Starpharma Holdings (SPHRY) Australia $0.401B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.397B 0.00
Affimed (AFMD) Germany $0.395B 0.00
Clovis Oncology (CLVS) United States $0.392B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.376B 17.71
AC Immune SA (ACIU) Switzerland $0.373B 0.00
Trevena (TRVN) United States $0.367B 0.00
Syros Pharmaceuticals (SYRS) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.363B 0.00
ANI Pharmaceuticals (ANIP) United States $0.362B 9.20
XOMA (XOMA) United States $0.360B 0.00
Selecta Biosciences (SELB) United States $0.353B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.350B 0.00
Athersys (ATHX) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.340B 0.00
Arbutus Biopharma (ABUS) United States $0.320B 0.00
ChromaDex (CDXC) United States $0.300B 0.00
Kamada (KMDA) Israel $0.295B 13.79
PDL BioPharma (PDLI) United States $0.292B 0.00
Verastem (VSTM) United States $0.289B 0.00
NextCure (NXTC) United States $0.281B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.278B 0.00
DBV Technologies S.A (DBVT) France $0.260B 0.00
Fortress Biotech (FBIO) United States $0.245B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
TELA Bio (TELA) United States $0.241B 0.00
Pluristem Therapeutics (PSTI) Israel $0.239B 0.00
Aptinyx (APTX) United States $0.216B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.194B 0.00
AquaBounty Technologies (AQB) United States $0.187B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Theratechnologies (THTX) Canada $0.182B 0.00
Eton Pharmaceuticals (ETON) United States $0.182B 0.00
Aptevo Therapeutics (APVO) United States $0.182B 0.00
Cerecor (CERC) United States $0.181B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 0.00
Bellus Health (BLU) Canada $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.162B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.159B 0.00
Kindred Biosciences (KIN) United States $0.158B 0.00
Dyadic (DYAI) United States $0.156B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.155B 0.00
Oncobiologics (OTLK) United States $0.154B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Idera Pharmaceuticals (IDRA) United States $0.141B 0.00
Abeona Therapeutics (ABEO) United States $0.139B 0.00
Celyad SA (CYAD) Belgium $0.134B 0.00
Lumos Pharma (LUMO) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Gritstone Oncology (GRTS) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.125B 0.00
Exicure (XCUR) United States $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Orgenesis (ORGS) United States $0.117B 243.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.115B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Cogent Biosciences (COGT) United States $0.108B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
Novogen (KZIA) Australia $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.092B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Synlogic (SYBX) United States $0.085B 0.00
Curis (CRIS) United States $0.081B 0.00
AnPac Bio-Medical Science (ANPC) China $0.080B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 33.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.063B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Edesa Biotech (EDSA) Canada $0.050B 0.00
Seelos Therapeutics (SEEL) United States $0.048B 0.00
Vaccinex (VCNX) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.042B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Titan Pharmaceuticals (TTNP) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Spherix (AIKI) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
MedAvail Holdings (MDVL) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00